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Original Article
Captopril in The Treatment of Cardiovascular 
Manifestations of Indian Red Scorpion (Mesobuthus 
Tamulus Concanesis Pocock) Envenomation
A Krishnan, RV Sonawane, DR Karnad
Abstract
Objectives : To study outcome of patients with scorpion envenomation treated with oral captopril in the ICU 
of a Tertiary Care, University Hospital in Mumbai.
Methods : Retrospective analysis of all patients with scorpion sting admitted to Medical Intensive Care Unit 
of a tertiary care university hospital in Mumbai between 1993 and 2003.
Results :  Of 38 patients with cardiovascular manifestations, six had tachycardia alone and 8 had hypertension; 
these patients received oral captopril 12.525 mg thrice daily with no deaths. Pulmonary oedema with 
normal blood pressure and high central venous pressure (CVP) was seen in 10 patients. Five patients had 
hypotension, low CVP but no pulmonary oedema; with fluid infusion, these patients had correction of low 
CVP and hypotension, but developed pulmonary oedema. Pulmonary oedema resolved in all 15 patients 
with captopril (6.2525 mg thrice daily); one patient died of ventricular tachycardia. Nine patients had 
cardiogenic shock; 6 patients, whose blood pressure improved with dopamine received, captopril; 1 of these 
6 died. The other three patients did not respond to maximum vasopressor therapy and could not be given 
captopril; all three died. Four of the 5 deaths occurred in patients weighing < 25 kg suggesting that severity 
of cardiovascular manifestations also depends on body weight of the victim.
Conclusion : Afterload reduction with oral captopril is safe and effective in scorpion envenomation with 
cardiovascular manifestations. Results are similar to those with other vasodilators.  ©
INTRODUCTION
Scorpion stings are common in tropical and subtropical  regions of the world. The major components of 
scorpion venom are short-chain peptides, which affect 
gating mechanisms of sodium and potassium channels 
in excitable tissues. α-toxins block voltage-dependent 
inactivation of sodium channels, resulting in persistent 
depolarization. β-toxins shift the voltage-dependent 
activation of these channels to a more negative membrane 
potential, making tissues more excitable.1,2 Blockade of 
potassium channels slows repolarization and prolongs 
the action potential in neurons and myocytes.2,3 The 
resultant intense persistent depolarization of autonomic 
nerves with massive release of neurotransmitters 
from the adrenal medulla and parasympathetic and 
sympathetic nerve endings.4,5 is largely responsible 
for the toxic cardiovascular manifestations. The toxin 
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may also directly affect myocardial contractility and 
excitability.6 Central nervous system effects include 
irritability, muscle rigidity, altered consciousness and 
convulsions.7
Unlike snake antivenom, antiserum against scorpion 
venom does not help in the treatment of systemic 
manifestation.8,9 Inotropic drugs like dopamine and 
dobutamine may produce hemodynamic improvement.10 
However, envenomation results in a catecholamine-
excess state and some studies suggest that these drugs 
alone may not reduce mortality.11,12 Vasodilators have 
been used in both hypertensive and hypotensive 
phases of envenomation. Nifedipine, prazosin, and 
sodium nitroprusside11,13,14,15 reduce left ventricular 
afterload, improving cardiovascular manifestations and 
reducing mortality. Angiotensin converting enzyme 
(ACE) inhibitors are used extensively in patients with 
congestive cardiac failure with improved survival. 
However, there are only anecdotal reports regarding 
use of captopril in scorpionism.11,16 We report here, 
our experience with use of captopril in scorpion 
envenomation.
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MATERIAL AND METHODS
All patients with scorpion sting admitted to Medical 
Intensive Care Unit of a tertiary care university hospital 
in Mumbai over a 10-year period were studied.  On 
admission, history (including distance of residence 
from hospital, time between sting and hospitalization, 
and prior treatment received) and physical examination 
findings were noted.  A 12-lead electrocardiogram 
(ECG) was recorded in all patients on admission and 
continuous ECG monitoring was carried out in all 
patients for at least 24 hours. A central venous catheter 
was placed in all patients with pulmonary oedema or 
hypotension. Radial artery pressure was invasively 
monitored in hypotensive patients.
The patients were categorized into five groups based 
on previously described hemodynamic patterns,17 viz. 
Group A - those with tachycardia (heart rate > 100/
minute) but normal blood pressure and no pulmonary 
oedema; Group B -  hypertension (BP > 140 systolic or 
90 diastolic); Group C - pulmonary oedema (presence of 
crackles in the lung fields with normal or elevated BP); 
Group D -  fluid-responsive hypotension (systolic arterial 
pressure (SAP) < 80 mm Hg which is corrected by fluid 
administration alone without need for inotropes) with or 
without pulmonary crackles  this group was similar to 
group C except that they were hypovolemic;  and Group 
E -  cardiogenic shock (SAP < 80mm Hg with signs of 
pulmonary oedema, lack of response to fluid infusion 
and need for inotropes to improve BP).  Pulmonary 
artery catheterization was done in only a few patients; 
these have been reported in detail earlier.17
Hypertensive patients were treated with 12.5 mg 
captopril orally, every 8 hours; the dose was increased 
to 25 mg in those who remained hypertensive. Patients 
with pulmonary oedema and systolic blood pressure 
(SBP)> 90 mmHg were administered 6.25 to 12.5 mg 
captopril orally every 8 hours. The dose was increased 
to 25 mg 8 hourly if pulmonary oedema persisted 
and SBP was > 90 mmHg. If captopril administration 
resulted in clearance of pulmonary oedema but caused 
hypotension, intravenous fluid challenges were given 
(200 ml of 0.9% saline over 15 minutes) till SBP exceeded 
90 mmHg. Patients who failed to respond to fluids were 
administered dopamine, but captopril was continued. 
Patients who were hypotensive on admission received 
prompt intravenous fluid resuscitation and dopamine 
was added if hypotension persisted after adequate 
volume repletion. These patients too received captopril 
once the systolic pressure rose to > 90 mmHg. Captopril 
was continued for 5 to 7 days after resolution of 
cardiovascular manifestations. Patients with respiratory 
failure due to pulmonary oedema were tracheally 
intubated and mechanically ventilated if necessary.
The StudentÊs t test or Mann-Whitney test were 
used for statistical comparison of continuous variables 
and chi-square test or FisherÊs exact test were used for 
proportions.  
RESULTS
Thirty-eight patients aged 13 to 59 years were 
admitted to the ICU following scorpion sting. Most 
patients were from rural areas in Western India.  Fifteen 
patients resided within 50 km from the hospital, 13 
patients stayed between 50-100 km away and 10 patients 
were from areas that were more than 100 km away. The 
mean Acute Physiology and Chronic Health Evaluation 
(APACHE) II score was 11 (range 2-30) and the mean 
interval between sting and hospital admission was 9.1 
hours (range 1 to 45 hours). 
Six patients had only tachycardia without changes 
in arterial pressure or pulmonary oedema (Table 1). 
Eight patients had systemic arterial hypertension but no 
pulmonary oedema. All 14 patients showed a prompt 
response to oral captopril and made an uneventful 
recovery. Pulmonary oedema and fluid-responsive 
hypotension were seen in 15 (39.4%) patients; 10 
patients had pulmonary oedema without hypotension 
and 5 had hypotension without pulmonary oedema on 
admission (Table 1). With fluid resuscitation, the latter 
five patients had improvement in arterial pressure, but 
developed signs of pulmonary oedema. All 15 patients 
showed a good response to oral captopril which was 
administered only after correction of hypotension 
with intravenous fluid. There was one death in this 
group  a thirteen years old boy (weight 20 kg) who 
had stable haemodynamics after day 1 in the ICU, but 
developed refractory ventricular tachycardia 4 days 
after admission.
Nine patients had cardiogenic shock on admission 
(Table 1). These patients had very high CVP, severe 
pulmonary edema, metabolic acidosis and peripheral 
circulatory failure. They were all treated with dopamine, 
and captopril was administered to six patients, only 
after hypotension was corrected. The other three 
patients continued to remain in cardiogenic shock and 
could not be given captopril; all three died. One of the 
six patients with cardiogenic shock who had received 
captopril died.
Other manifestations
Seventeen patients (44.7%) had pain at the site of 
the bite. Two patients had severe vomiting and three 
had profuse sweating as major complaints. ECG 
changes in the form of ST depression, T wave inversion 
or ventricular premature complexes were seen in 
15 patients (39.4%). The incidence of ECG changes 
increased with increased severity of cardiovascular 
dysfunction (Table 1).
Outcome and Prognostic Factors
The overall mortality was 13.1% (5 deaths). Factors 
associated with poor outcome included increasing 
cardiovascular dysfunction, younger age, body weight 
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of 25 kg or less, longer interval between sting and 
hospital admission, and presence of hyponatremia, 
hypokalaemia, elevated transaminases, leukocytosis 
and metabolic acidosis. Blood glucose levels did not 
differ in survivors and nonsurvivors (Table 2).  
DISCUSSION
Most cases of envenomation in western India 
are following stings by Mesobuthus tamulus (red 
scorpion).17 While the species of scorpions differ from 
region to region, there is considerable similarity in the 
cardiovascular manifestations produced by them.7 The 
mildest form of envenomation produces tachycardia 
and hypertension; this was seen in 14 (37%) of our 
patients with no deaths. These patients presented early, 
and responded promptly to treatment with captopril. 
Hemodynamics studies in hypertensive patients have 
shown a predominantly vascular effect with normal 
cardiac output. The systemic vascular resistance (SVR) 
may be increased upto four times normal with normal 
pulmonary artery and pulmonary capillary wedge 
pressures.17
Severe envenomation results in pulmonary oedema, 
which has been shown to respond well to diuretics. 
However, while plasma volume contraction by 
diuresis improves pulmonary oedema, it produces 
hypotension;11 fluid replenishment results in the re-
appearance of pulmonary oedema.17 This syndrome 
can be effectively treated by captopril.11 Hemodynamic 
studies have shown that these patients have a depressed 
myocardial function with normal SVR.17 It is not clear 
why the SVR should drop in patients with more 
severe forms envenomation.  Among the mechanisms 
postulated include cholinergic stimulation, release of 
histamine, nitric oxide and kinins7 or a direct effect 
of toxin on vascular smooth muscle.7,18 Pulmonary 
oedema and fluid-responsive hypotension were seen 
in 15 (39.4%) patients. All patients responded well to 
treatment with captopril and fluid infusion, with only 
one death. This patientÊs pulmonary oedema resolved, 
but he died of refractory ventricular tachycardia 4 days 
after envenomation.
Cardiogenic shock represents the most severe stage of 
scorpionism. Gueron et al have demonstrated interstitial 
oedema, cellular infiltration and myocarditis with 
focal areas of myocardial degeneration and necrosis in 
Table 1 :  Various clinical presentations of patients with scorpion envenomation
 Tachycardia Hypertension Pulmonary oedema Fluid-responsive Cardiogenic shock
   without hypotension hypotension
Number of patients 6 8 10 5 9
Mean arterial pressure (mm Hg)* 100 μ 9 132 μ 30 84 μ 8 61 μ 2 56 μ 8
Time after sting (hours)* 3.2 μ 3.1 3.0 μ 2.7 7.2 μ 4.7 16.0 μ 19.4 17.4 μ 5.3
Central nervous system affection 0 1 0 0 3
Hypoxia 0 0 7 1 6
Electrocardio-graphic changes 0 0 4 (40%) 2 (40%) 9 (100%)
Died  (%) 0 0 1 (10%) 0 4 (44%)
*values are mean μ sd
Table 2 : Differences in clinical and laboratory parameters among survivors and non-survivors in patients 
with scorpion sting
Parameters Survived (n = 33) Died (n = 5) p value
Age (years) 30 (21 - 39) 14 (13-20) 0.007
Weight (Kg) < 25kg 1 4
       > 25kg 32 1 <0.001
Time after sting (hours) 5.5 (2 - 9.75) 14 (12.5  18.0) 0.017
Mean arterial pressure (mmHg) 83.3 (68  114) 66.7 (58  72) 0.026
APACHE II score 9 (5 12) 23 (18 29) <0.001
Arterial pH 7.42(7.36  7.47) 7.25(7.19  7.33) 0.007
Arterial pO2 (mm Hg) 71 (56-84) 45 (44-54) 0.006
Hemoglobin (g/dL) 12.5 (11.6-13.8) 11.6(10.4-13.9) NS
Total leukocyte count (per mm3) 12200(8500-16500) 20500(17850-30000) 0.005
Serum AST (units/L) 45 (36  57) 146 (65  248) 0.01
Serum ALT (units/L) 40 (24  48) 63 (43  170) 0.033
Serum creatinine (mg/dl) 1.1 (0.9  1.2) 1.6 (1.35  1.9) 0.004
Serum sodium (mEq/L) 136 (132 140) 127 (123 133) 0.012
Serum potassium (mEq/L) 3.6 (3.2 3.8) 2.8 (2.6  3.3) 0.01
Admission blood glucose (mg/dl) 116 (96  143) 126 (111  160) NS
All values are median (interquartile range) except weight, where number of patients is mentioned. 
Abbreviations: NS, not significant; APACHE, Acute Physiological and Chronic Health Evaluation; 
AST, Aspartate aminotransferase; ALT, Alanine aminotransferase
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patients dying of scorpion envenomation.18 Increased 
myocardial oxygen consumption due to intense 
catecholamines and angiotensin surge,4,5,20 alterations 
in myocardial blood flow7, 21 and a direct toxic effect 
cause the „myocarditis,‰ depressed left ventricular 
function as well as life-threatening cardiac arrhythmias. 
Hemodynamically, this phase is characterized by low 
cardiac output, elevated pulmonary wedge pressure, 
signs of pulmonary congestion and refractoriness 
to inotropic drugs. This was seen in 9 (23.7%) of our 
patients with four deaths (44.4%). All patients received 
dopamine infusions. Captopril could be administered 
to only six patients after correcting hypotension. In the 
other three patients hypotension could not be corrected; 
all three died. Das et al have found that ECG changes 
are a sensitive marker of myocardial injury;22 all our 9 
patients in this group had ECG changes.
Unlike the present study, previous authors have 
classified patients not according to hemodynamics, but 
by the presence of pulmonary oedema. Bawaskar et al 
have reported 121 patients with scorpion envenomation 
treated with prazosin, with an overall mortality of only 
8%. However, a majority of these patients had mild 
hemodynamic disturbances; in the 31 patients who had 
pulmonary oedema there were 9 deaths (mortality 29%) 
in this series.23,24 Similarly, two studies from Tunisia 
have reported 11% mortality in comparable patients 
treated with dobutamine.25,10 In the present study, 5 
deaths (21% mortality) occurred in 24 patients with 
pulmonary oedema treated with captopril.  Mortality 
was 44.4% in patients with cardiogenic shock. Only 2 
previous studies have described patients with shock as 
a separate subgroup. Seventy five percent mortality was 
reported by Bawaskar and Bawaskar in patients with 
shock treated with prazosin23 and 100% mortality in a 
Brazilian study where vasodilators were not used.26
In patients with left ventricular dysfunction, ACE 
inhibitors help by afterload reduction, decreasing 
sympathetic activity, improving endothelial function 
and preventing myocardial apoptosis.27,28 The present 
study clearly shows that captopril may be effective 
in treating cardiovascular manifestations following 
scorpion sting with mortality comparable to that using 
other vasodilators, including prazosin. Previous reports 
on the hemodynamics of scorpion envenomation and the 
effects of captopril support the physiological rationale 
of its use. Bawaskar et al have extensively studied the 
clinical benefits of using prazosin as a vasodilator in 
treatment of scorpion envenomation.12,13,30,31 Although 
clinically very useful in the management of the 
cardiovascular manifestations, hemodynamic studies 
of the effect of prazosin are lacking. Some authors 
had expressed reservations about their use because 
these drugs also inhibit kininase II, which could result 
in increased bradykinin levels.  Experiments in rats 
suggest that bradykinin may increase pulmonary 
capillary permeability and contribute to venom-induced 
pulmonary oedema.32 However, several hemodynamic 
studies in humans have convincingly demonstrated 
that pulmonary oedema is mainly cardiogenic.25, 33 and 
that vasodilators including captopril relieve pulmonary 
oedema and enhance cardiac output. Moreover, ACE 
inhibitors may also help by their direct action of opening 
calcium-activated potassium channels, which are 
blocked by scorpion toxins.3
The proportion of patients with severe cardiovascular 
manifestations in our study is high, mainly due to 
the referral pattern. Most of these patients resided in 
remote rural areas with inadequate medical facilities 
and presented significantly later after the sting. Many 
patients had been treated in rural hospital and referred 
after conventional therapy had failed. It is not clear 
whether the severity of manifestations is due to more 
severe envenomation, or due to prolonged hypotension 
and hypoxia resulting from delay in transport to an 
urban tertiary hospital. However, in a large series from 
rural India, Bawaskar et al have also found that patients 
who present later have more severe manifestations 
with high mortality.23 Notably, 4 of the 5 deaths in our 
study occurred in patients who weighed less than 25 kg, 
suggesting that severity of cardiovascular effects may 
also depend on body weight of the victim. 
In conclusion, captopril appears to be safe and 
effective in scorpion envenomation. This study also 
shows that it is possible to administer captopril in over 
90% of patients after correction of hypotension with fluid 
resuscitation and inotropic drugs. Overall mortality in 
the present series was 13.1% despite the fact that a large 
proportion of patients had severe envenomation and 
presented after a considerable delay after scorpion sting. 
A major limitation of our study is that cardiovascular 
hemodynamics were not studied by pulmonary artery 
catheterization in all patients. Nevertheless, the protocol 
used is simple and can easily be implemented in even 
primary healthcare facilities in rural areas. 
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